What is the address of MED SAY?

The registered office of MED SAY is located at Rue Joseph Wauters 22, 6200 Châtelet.

Is MED SAY still active?

Yes. According to the CBE (29 September 2026) MED SAY is active, legal situation “Normale toestand”, started on 4 October 2024.

Is MED SAY registered on Peppol?

Yes, MED SAY is registered on the Peppol network with ID 0208:1014677210.

What is the enterprise number of MED SAY?

The enterprise number of MED SAY is BE1014677210.

When was MED SAY founded?

MED SAY was founded on 4 October 2024.

Who are the directors of MED SAY?

According to the 2025 annual accounts, the directors of MED SAY are: Selçuk Say.

Is MED SAY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 October 2024; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MED SAY make in 2025?

MED SAY posted a profit after taxes of € 89,217 in financial year 2025.

What is the revenue of MED SAY?

As a small company, MED SAY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 118,998.

MED SAY (Private Limited) - Châtelet - BE1014677210

Dossier MED SAY, printed on 29 September 2026 from databakkes.be/en/1014677210/med-say. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MED SAY from Châtelet, company number BE1014677210, closed financial year 2025 with a result of € 89,217 after tax. For that financial year MED SAY recorded a gross margin of € 118,998 and equity of € 131,629. Compared with financial year 2024, the result moved from € 39,911 to € 89,217. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 19, 2026.

What it is worth Growing

€ 131,629

▲ 210% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 89,217

▲ 124% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 144,411

▲ € 120,737 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 129,129.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,829

▲ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,777

▲ 114% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,515

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 51,599 Gross margin 2024: € 51,599 First fiscal year in the series	€ 118,998 Gross margin 2025: € 118,998 ▲ 131% vs 2024 (€ 51,599) Favourable step	▲ 131%
Profit after taxes	€ 39,911 Profit after taxes 2024: € 39,911 First fiscal year in the series	€ 89,217 Profit after taxes 2025: € 89,217 ▲ 124% vs 2024 (€ 39,911) Favourable step	▲ 124%
Equity	€ 42,411 Equity 2024: € 42,411 First fiscal year in the series	€ 131,629 Equity 2025: € 131,629 ▲ 210% vs 2024 (€ 42,411) Favourable step	▲ 210%
Total debts	€ 15,137 Total debts 2024: € 15,137 First fiscal year in the series	€ 47,053 Total debts 2025: € 47,053 ▲ 211% vs 2024 (€ 15,137) Unfavourable step	▲ 211%
Cash	€ 23,675 Cash 2024: € 23,675 First fiscal year in the series	€ 144,411 Cash 2025: € 144,411 ▲ € 120,737 vs 2024 (€ 23,675) Favourable step	▲ € 120,737
Retained profit	€ 39,911 Retained profit 2024: € 39,911 First fiscal year in the series	€ 129,129 Retained profit 2025: € 129,129 ▲ 224% vs 2024 (€ 39,911) Favourable step	▲ 224%
Balance sheet total	€ 57,548 Balance sheet total 2024: € 57,548 First fiscal year in the series	€ 178,682 Balance sheet total 2025: € 178,682 ▲ 210% vs 2024 (€ 57,548) Unchanged	▲ 210%

Key figures of MED SAY, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MED SAY?

What happened at MED SAY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 19, 2026 New annual accounts for financial year 2025: profit of € 89,217 (▲ 124% vs 2024). filed late Source: NBB ↗
Oct 4, 2024 New establishment in Châtelet. KBO
2024 Selçuk Say became a director. NBB
Oct 4, 2024 Start of the company according to the CBE. KBO

In short

From € 39,911 profit in 2024 to € 89,217 profit in 2025.

Paid € 37,276 in corporate taxes since 2024.

Best year ever: 2025, with € 89,217 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MED SAY? We notify you, reason included.

Follow MED SAY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Selçuk Say

MED SAY

Behind MED SAY is Selçuk Say.

See the full network in the app

Directors

According to the 2025 annual accounts

Selçuk Say

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Joseph Wauters 22

6200 Châtelet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1014.677.210
VAT number: BE 1014.677.210
Registered office: Rue Joseph Wauters 22, 6200 Châtelet
Names & denominations: MED SAY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 October 2024
Peppol: Active · Active since 5 Oct 2025

View on CBE Public ↗ Annual accounts (NBB) ↗